ASSOCIATION BETWEEN LOWER ESTIMATED GLOMERULAR FILTRATION RATE (GFR) AND INCIDENT CANCER: A REPORT FROM THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART ATTACK TRIAL (ALLHAT)

被引：0
|
作者：
Chen, D.
Pressel, S.
Davis, B.
Dobre, M.
Muntner, P.
Sarnak, M.
Simpson, L.
Whelton, P.
Wright, J. T.
Rahman, M.
机构：
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2014年 / 63卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
77
引用
收藏
页码：A38 / A38
页数：1
相关论文
共 50 条
  • [1] Angioedema in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Piller, L
    Ford, C
    Davis, B
    Nwachuku, C
    Black, H
    Oparil, S
    Gappy, S
    Retta, T
    Probstfield, J
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 92A - 92A
  • [2] Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) - Practical implications
    Oparil, S
    HYPERTENSION, 2003, 41 (05) : 1006 - 1009
  • [3] Antihypertensive and lipid-lowering treatment to prevent heart attack (ALLHAT) trial: Interim results
    Davis, B
    Furberg, CD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (01) : 325 - 325
  • [4] Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Pressel, S
    Davis, BR
    Louis, GT
    Whelton, P
    Adrogue, H
    Egan, D
    Farber, M
    Payne, G
    Probstfield, J
    Ward, H
    CONTROLLED CLINICAL TRIALS, 2001, 22 (06): : 674 - 686
  • [5] Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)
    Dhruva, Sanket S.
    Huang, Chenxi
    Spatz, Erica S.
    Coppi, Andreas C.
    Warner, Frederick
    Li, Shu-Xia
    Lin, Haiqun
    Xu, Xiao
    Furberg, Curt D.
    Davis, Barry R.
    Pressel, Sara L.
    Coifman, Ronald R.
    Krumholz, Harlan M.
    HYPERTENSION, 2017, 70 (01) : 94 - 102
  • [6] Long-Term Renal and Cardiovascular Outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants by Baseline Estimated GFR
    Rahman, Mahboob
    Ford, Charles E.
    Cutler, Jeffrey A.
    Davis, Barry R.
    Piller, Linda B.
    Whelton, Paul K.
    Wright, Jackson T., Jr.
    Barzilay, Joshua I.
    Brown, Clinton D.
    Colon, Pedro J., Sr.
    Fine, Lawrence J.
    Grimm, Richard H., Jr.
    Gupta, Alok K.
    Baimbridge, Charles
    Haywood, L. Julian
    Henriquez, Mario A.
    Ilamaythi, Ekambaram
    Oparil, Suzanne
    Preston, Richard
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (06): : 989 - 1002
  • [7] Blood pressure control in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Cushman, WC
    Ford, CE
    Cutler, JA
    Margolis, KL
    Davis, BR
    Grimm, RH
    CIRCULATION, 2002, 106 (19) : 476 - 476
  • [8] Results of clinical evidence - Antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Lyakishev, AA
    KARDIOLOGIYA, 2003, 43 (04) : 61 - 62
  • [9] The antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Flack, JM
    Nasser, SA
    CURRENT HYPERTENSION REPORTS, 2003, 5 (03) : 189 - 191
  • [10] Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Barzilay, JI
    Jones, CL
    Davis, BR
    Basile, JN
    Goff, DC
    Ciocon, JO
    Sweeney, ME
    Randall, OS
    DIABETES CARE, 2001, 24 (04) : 654 - 658
12345